Tag #Cancer Vaccine

Showing 13 to 16 of 16 results

repubblica.it

🌐 85% Global Worthiness

Jan 15, 16:10

Shared Neoantigens in Endometrial Cancers Suggest Potential for Nous-209 Vaccine

An Italian study found that endometrial cancers with mismatch repair deficiency share many neoantigens with colon and stomach cancers, suggesting the potential use of the existing Nous-209 therapeutic vaccine; 80% of 35 patients showed at least one neoantigen present in Nous-209.

Shared Neoantigens in Endometrial Cancers Suggest Potential for Nous-209 Vaccine

An Italian study found that endometrial cancers with mismatch repair deficiency share many neoantigens with colon and stomach cancers, suggesting the potential use of the existing Nous-209 therapeutic vaccine; 80% of 35 patients showed at least one neoantigen present in Nous-209.

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the study's finding of shared neoantigens between different cancer types contribute to the development of therapeutic cancer vaccines?

This pre-clinical proof-of-concept study establishes a rationale for expanding Nous-209 trials to include endometrial cancer patients. The shared neoantigens, resulting from mismatch repair defects, indicate a potential mechanism for effective immunotherapy across multiple cancer types. Eighty percent of the endometrial cancer patients studied possessed at least one neoantigen present in Nous-209.

dailymail.co.uk

🌐 85% Global Worthiness

Dec 17, 01:10

Russia Announces Free Personalized Cancer Vaccine for 2025 Rollout

Russia's health ministry announced a free, personalized cancer vaccine for patients, launching in early 2025, addressing the nation's rising cancer rates exceeding 635,000 cases in 2022, using RNA technology similar to Western approaches.

Russia Announces Free Personalized Cancer Vaccine for 2025 Rollout

Russia's health ministry announced a free, personalized cancer vaccine for patients, launching in early 2025, addressing the nation's rising cancer rates exceeding 635,000 cases in 2022, using RNA technology similar to Western approaches.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of Russia's announcement of a free, personalized cancer vaccine?

Russia's health ministry announced a free, personalized cancer vaccine launching in early 2025. The vaccine, designed for cancer patients, uses RNA from a patient's tumor to trigger an immune response against cancer cells. Details on which cancers it treats and its effectiveness remain undisclosed.

pda.kp.ru

🌐 85% Global Worthiness

Jan 9, 16:11

Key Scientific Advancements to Watch in 2025

KP.RU reports on several key scientific advancements for 2025: a Venus mission searching for life (launching January 2025), clinical trials for a personalized Russian mRNA cancer vaccine (patient availability mid-2025), a partial solar eclipse visible in parts of North America and northern Russia on...

Key Scientific Advancements to Watch in 2025

KP.RU reports on several key scientific advancements for 2025: a Venus mission searching for life (launching January 2025), clinical trials for a personalized Russian mRNA cancer vaccine (patient availability mid-2025), a partial solar eclipse visible in parts of North America and northern Russia on...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the broader societal impacts and future trends that these developments might signify?

The success of these scientific endeavors may have significant long-term implications. The discovery of life on Venus could revolutionize our understanding of biology and the potential for life beyond Earth. The cancer vaccine's success could transform cancer treatment, offering a personalized approach to combatting various tumor types. The increased accuracy of astronomical predictions further cements our comprehension of celestial mechanics and allows for precise planning of future observations.

pda.kp.ru

🌐 85% Global Worthiness

Dec 17, 19:11

Russia Begins Human Trials of Personalized Cancer Vaccine

Russia is conducting human clinical trials for "EnteroMix," a personalized cancer vaccine using oncolytic viruses, targeting patients with solid tumors who have exhausted standard treatment options, offering a potentially revolutionary approach to cancer treatment.

Russia Begins Human Trials of Personalized Cancer Vaccine

Russia is conducting human clinical trials for "EnteroMix," a personalized cancer vaccine using oncolytic viruses, targeting patients with solid tumors who have exhausted standard treatment options, offering a potentially revolutionary approach to cancer treatment.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of Russia's clinical trials for the "EnteroMix" cancer vaccine?

Russia is developing two cancer vaccines, one of which, "EnteroMix," is undergoing human clinical trials. Unlike preventative vaccines, this vaccine stimulates the immune system to fight existing cancer by using a patient's own tumor cells to create a personalized vaccine.

Showing 13 to 16 of 16 results